LABA step-off in asthma patients: black-box warning may need reevaluation Review 14 January 2013 Pages: 1 - 1
As part of the move to create a joint regulatory agency, the Australian Therapeutic Goods Administration (TGA) and the New Zealand's Medsafe News item 14 January 2013 Pages: 2 - 2
The Drugs Controller General (India), FDA Bhawan New Delhi, has mandated that a boxed warning be added to the labels of nimesulide formulations News item 14 January 2013 Pages: 2 - 2
The UK's MHRA has ruled that products containing 1,3-dimethylamylamine (DMAA) must be removed from the UK market Media release 14 January 2013 Pages: 3 - 3
A safety advisory regarding the use of insulin pumps manufactured by Animas Corporation has been issued by the Irish Medicines Board (IMB). News item 14 January 2013 Pages: 3 - 3
A pilot program enabling patients/consumers to directly report suspected ADRs in Japan News item 14 January 2013 Pages: 3 - 3
Idenex Pharmaceuticals, Inc. have had a clinical hold placed by the US FDA on IDX-19368, Media release 14 January 2013 Pages: 3 - 3
The US FDA has notified the cystic fibrosis (CF) community about the possible risk of cataract development in children taking ivacaftor [Kalydeco]. News item 14 January 2013 Pages: 3 - 3
The US FDA have issued a Class I recall for I-Flow Corporation's ON-Q Pump with ONDEMAND Bolus Button, News item 14 January 2013 Pages: 3 - 3
Roche has sent out a 'Dear Healthcare Professional' letter in the UK regarding new concentration and dosing instructions for Tamiflu News item 14 January 2013 Pages: 3 - 3
The UK's Commission on Human Medicines has provided new guidance on the use of IV acetylcysteine for paracetamol [acetaminophen] overdose. News item 14 January 2013 Pages: 3 - 3
Statins: reporting rates for muscle-related ADRs differ substantially Incidence study 14 January 2013 Pages: 4 - 4
Clozapine: higher rates of GORD than other atypical antipsychotics Epidemiology clinical study 14 January 2013 Pages: 4 - 4
Caution recommended for glucocorticoids after tonsillectomy Clinical study 14 January 2013 Pages: 4 - 4
High prevalence of resistance to second-line anti-TB drugs Epidemiology clinical study 14 January 2013 Pages: 4 - 4
Cefazolin: lower treatment failure risk than vancomycin for MSSA Epidemiology clinical study 14 January 2013 Pages: 5 - 5
New scale for assessing epilepsy drug side effects in children Clinical study 14 January 2013 Pages: 5 - 5
No link between analgesic use and postmenopausal breast cancer Epidemiology clinical study 14 January 2013 Pages: 5 - 5
